The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Grutsch, James F ^a,d   Ferrans, Carol ^d   Wood, Patricia A ^b   Du Quiton, Jovelyn ^b   Quiton, Dinah F T ^c   Reynolds, Justin L ^b   Ansell, Christine M ^b   Oh, Eun Y ^b   Daehler, Mary A ^a   Levin, Robert D ^a   Braun, Donald P ^a   Gupta, Digant ^a   Lis, Christopher G ^a   Hrushesky, William J M ^b,c  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIMETRY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG CANCER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP PATTERN; SYMPTOM; TREATMENT FAILURE; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ACTIGRAPHY; ADULT; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 79956213167     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-193     Document Type: Article

References (55)

1. Halberg F. Temporal coordination of physiologic function. Cold Spring Harb Symp Quant Biol 1960, 25:289-310.
2. Aschoff J. Circadian Rhythms In Man. Science 1965, 148:1427-32. 10.1126/science.148.3676.1427, 14294139.
3. Lin JD, Liu C, Li S. Integration of energy metabolism and the mammalian clock. Cell Cycle 2008, 7:453-7. 10.4161/cc.7.4.5442, 18235232.
4. Karatsoreos IN, Silver R. Minireview: The neuroendocrinology of the suprachiasmatic nucleus as a conductor of body time in mammals. Endocrinology 2007, 148:5640-7. 10.1210/en.2007-1083, 17901227.
5. Panda S, Hogenesch JB, Kay SA. Circadian rhythms from flies to human. Nature 2002, 417:329-35. 10.1038/417329a, 12015613.
6. Wever R. The circadian multi-oscillatory system of man. Int J Chronobiol 1975, 3:19-55.
7. Moore RY, Eichler VB. Central neural mechanisms in diurnal rhythm regulation and neuroendocrine responses to light. Psychoneuroendocrinology 1976, 1:265-79. 10.1016/0306-4530(76)90016-0, 792940.
8. Souetre E, Salvati E, Belugou JL, et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989, 28:263-78. 10.1016/0165-1781(89)90207-2, 2762432.
9. Foster RG, Roenneberg T. Human responses to the geophysical daily, annual and lunar cycles. Curr Biol 2008, 18:R784-R794. 10.1016/j.cub.2008.07.003, 18786384.
10. Levin RD, Daehler MA, Grutsch JF, et al. Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 2005, 93:1202-8. 10.1038/sj.bjc.6602859, 2361523, 16265345.
11. Rich T, Innominato PF, Boerner J, et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005, 11:1757-64. 10.1158/1078-0432.CCR-04-2000, 15755997.
12. Le Guen Y, Gagnadoux F, Hureaux J, et al. Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer 2007, 58:139-43. 10.1016/j.lungcan.2007.05.021, 17614157.
13. Hrushesky WHE, Lakatua D, Langevin T, Halberg F, Kennedy B. Marker rhythms for cancer chrono-chemotherapy. Chronobiology 1985, 493-499. Haus E, Cabet H.
14. Mormont MC, Waterhouse J, Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000, 6:3038-45.
15. Iurisci I, Rich T, Levi F, et al. Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer. J Clin Oncol 2007, 25:e17-9. 10.1200/JCO.2007.11.3274, 17538154.
16. Ancoli-Israel S, Liu L, Marler MR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006, 14:201-9. 10.1007/s00520-005-0861-0, 1599708, 16010529.
17. Davidson JR, MacLean AW, Brundage MD, et al. Sleep disturbance in cancer patients. Soc Sci Med 2002, 54:1309-1321. 10.1016/S0277-9536(01)00043-0, 12058848.
18. Mercadante S, Girelli D, Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer 2004, 12:355-9. 10.1007/s00520-004-0623-4, 15064937.
19. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003, 97:2919-25. 10.1002/cncr.11382, 12767108.
20. Mormont MC, Waterhouse J. Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int 2002, 19:313-23. 10.1081/CBI-120002606, 11962684.
21. Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006, 14:831-6.
22. Ferrans CE. Differences in what quality-of-life instruments measure. J Natl Cancer Inst Monogr 2007, 22-6.
23. Wilson IB, Cleary PD. Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Med Care 1996, 34:610-23. 10.1097/00005650-199606000-00010, 8656726.
24. Sadeh A, Alster J, Urbach D, et al. Actigraphically based automatic bedtime sleep-wake scoring: validity and clinical applications. J of Ambulatory Monitoring 1989, 2:209-216.
25. Jean-Louis G, von Gizycki H, Zizi F, et al. Determination of sleep and wakefulness with the actigraph data analysis software (ADAS). Sleep 1996, 19:739-743.
26. Sadeh A, Sharkey KM, Carskadon MA. Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep 1994, 17:201-7.
27. Korszun A, Young EA, Engleberg NC, et al. Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. J Psychosom Res 2002, 52:439-43. 10.1016/S0022-3999(01)00237-9, 12069867.
28. Cole RJ, Kripke DF, Gruen W, et al. Automatic sleep/wake identification from wrist activity. Sleep 1992, 15:461-9.
29. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-76. 10.1093/jnci/85.5.365, 8433390.
30. Bottomley A. The cancer patient and quality of life. Oncologist 2002, 7:120-5. 10.1634/theoncologist.7-2-120, 11961195.
31. Ferrans CE. Definitions and conceptual models of quality of life. 2005, Cambridge, UK, Cambride University Press.
32. Scott NW, Fayers PM, Aaronson NK, et al. EORTC Reference Manual 2008. 2008, Brussels, Belgium, EORTC Quality of Life Group.
33. Hjermstad MJ, Fayers PM, Bjordal K, et al. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ = C30 (+ 3). J Clin Oncol 1998, 16:1188-96.
34. Gupta D, Grutsch JF, Lis CG. Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30. J Soc Integr Oncol 2008, 6:13-8.
35. Ancoli-Israel S, Cole R, Alessi C, et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26:342-92.
36. Murphy F, Bentley S, Ellis BW, et al. Sleep deprivation in patients undergoing operation: a factor in the stress of surgery. Br Med J 1977, 2:1521-2. 1632817, 589313.
37. Bentley S, Murphy F, Dudley H. Perceived noise in surgical wards and an intensive care area: an objective analysis. Br Med J 1977, 2:1503-6. 10.1136/bmj.2.6101.1503, 1632803, 589305.
38. Salas RE, Gamaldo CE. Adverse effects of sleep deprivation in the ICU. Crit Care Clin 2008, 24:461-76. v-vi, 10.1016/j.ccc.2008.02.006, 18538195.
39. Hunter P. To sleep, perchance to live. Sleeping is vital for health, cognitive function, memory and long life. EMBO Rep 2008, 9:1070-3. 10.1038/embor.2008.197, 2581860, 18978807.
40. Lin YM, Chang JH, Yeh KT, et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinogensis 2008, 47:925-33.
41. Filipski E, King VM, Li X, et al. Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris) 2003, 51:216-9.
42. Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res 2009, 46:245-7. 10.1111/j.1600-079X.2009.00665.x, 19215573.
43. Penev PD, Kolker DE, Zee PC, et al. Chronic circadian desynchronization decreases the survival of animals with cardiomyopathic heart disease. Am J Physiol 1998, 275:H2334-7.
44. Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007, 30:1659-66. 2276139, 18246975.
45. Sephton SE, Sapolsky RM, Kraemer HC, et al. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000, 92:994-1000. 10.1093/jnci/92.12.994, 10861311.
46. Hrushesky WJ. Circadian timing of cancer chemotherapy. Science 1985, 228:73-5. 10.1126/science.3883493, 3883493.
47. Rich TA. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J Support Oncol 2007, 5:167-74. discussion 176-7.
48. Mackiewicz M, Shockley KR, Romer MA, et al. Macromolecule biosynthesis: a key function of sleep. Physiol Genomics. 2007, 31:441-57.
49. Mystakidou K, Parpa E, Tsilika E, et al. The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep 2007, 30:737-42. 1978346, 17580595.
50. Beck SL, Schwartz AL, Towsley G, et al. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 2004, 27:140-8. 10.1016/j.jpainsymman.2003.12.002, 15157038.
51. Nakamura T, Takumi T, Takano A, et al. Of mice and men--universality and breakdown of behavioral organization. PLoS One 2008, 3:e2050. 10.1371/journal.pone.0002050, 2323110, 18446212.
52. Bogdan A, Lellouch J, Misset J-L, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000, 6:3038-45.
53. Berger AM, Farr LA, Kuhn BR, et al. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 2007, 33:398-409. 10.1016/j.jpainsymman.2006.09.022, 1892632, 17397701.
54. Satlin A, Teicher MH, Lieberman HR, et al. Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology 1991, 5:115-26.
55. Ancoli-Isreal S, Clopton P, Klauber MR, et al. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997, 20:24-27. 2762477, 9130330.